Expression Of CD25 Antigen On CD34+Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

被引:0
|
作者
Kotsianidis, Ioannis
Miltiades, Paraskevi
Lamprianidou, Eleftheria
Vassilakopoulos, Theodoros
Papageorgiou, Sotirios G.
Galanopoulos, Athanasios G.
Vakalopoulou, Sofia
Garypidou, Vassilia
Spanoudakis, Emmanouil
Papaioannou, Maria
Hadjiharissi, Evdoxia
Papadaki, Helen A.
Tsatalas, Costas
机构
关键词
D O I
10.1182/blood.V122.21.1508.1508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1508
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Cell cycling status of human cord blood CD34+cells during ex vivo expansion is related to the level of very late antigen expression
    Seoh, JY
    Park, HY
    Chung, WS
    Kim, SC
    Hahn, MJ
    Kim, KH
    Shin, HY
    Ahn, HS
    Park, KW
    Ryu, KH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (01) : 20 - 24
  • [32] Differential gene expression of bone marrow-derived CD34+cells is associated with survival of patients suffering from myelodysplastic syndrome
    Prall, Wolf C.
    Czibere, Akos
    Grall, Franck
    Spentzos, Dimitrios
    Steidl, Ulrich
    Giagounidis, Aristoteles Achilles Nikolaus
    Kuendgen, Andrea
    Otu, Hasan
    Rong, Astrid
    Libermann, Towia A.
    Germing, Ulrich
    Gattermann, Norbert
    Haas, Rainer
    Aivado, Manuel
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 173 - 187
  • [33] Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
    Pellagatti, A
    Cazzola, M
    Giagounidis, A
    Malcovati, L
    Killick, S
    Ramasamy, A
    Oscier, D
    Aul, C
    Wainscoat, JS
    Boultwood, J
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 60 - 60
  • [34] CD38 Expression On CD34+Cells as a Single Flow Cytometric Parameter to Distinguish Myelodysplastic Syndromes (MDS) From Non-Clonal Cytopenias.
    Alhan, Canan
    Westers, Theresia. M.
    Cali, Claudia
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    BLOOD, 2009, 114 (22) : 1089 - 1089
  • [35] Phenotypic aberrations of myeloid CD34+cells in patients with myelodysplastic syndrome (MDS):: Clinical significance and correlation with cytogenetics abnormalities.
    Subira, D
    Font, P
    Arranz, E
    Ramiro, S
    Castanon, S
    Renedo, M
    Blas, C
    Garcia, MF
    Gonzalez, O
    Tomas, JF
    Fernandez-Rañada, JM
    BLOOD, 2004, 104 (11) : 652A - 652A
  • [36] Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate
    Sheikhet, Helena Migalovich
    Hidalgo, Jose Villacorta
    Fisch, Paul
    Balbir-Gurman, Alexandra
    Braun-Moscovici, Yolanda
    Bank, Ilan
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [37] Expression of TGF-b1, VEGF and bFGF in pheripheral blood CD34+cells, unpurified BMMNC and PBMNC of patients with myeloproliferative disease and MDS.
    Grossi, A
    Biscardi, M
    Gavazzi, S
    Balestri, F
    Fabbri, A
    Morfini, M
    BLOOD, 2001, 98 (11) : 279B - 279B
  • [38] Altered gene expression in CD34+cells from PBSC grafts from patients developing t-MDS following autologous transplantation for lymphoma.
    Li, Liang
    Wu, Xiwei
    Radich, Jerald P.
    Zhao, Lue Ping
    Francisco, Liton
    Komiya, Asako
    Damasco, Holly
    Forman, Stephen J.
    Bhatia, Smita
    Bhatia, Ravi
    BLOOD, 2006, 108 (11) : 659A - 659A
  • [39] Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+cells of hypertensive patients
    Pirro, Matteo
    Schillaci, Giuseppe
    Menecali, Cinzia
    Bagaglia, Francesco
    Paltriccia, Rita
    Vaudo, Gaetano
    Mannarino, Massimo R.
    Mannarino, Elmo
    JOURNAL OF HYPERTENSION, 2007, 25 (10) : 2093 - 2099
  • [40] Reduced CD26 dipeptidylpeptidase IV membrane expression and activity of CD34+cells from patients with myelofibrosis with myeloid metaplasia.
    Campanelli, Rita
    Massa, Margherita
    Rosti, Vittorio
    Bergamaschi, Gaetano
    Viarengo, Gianluca
    Marchetti, Monia
    Hoffman, Ronald
    Barosi, Giovanni
    BLOOD, 2006, 108 (11) : 1033A - 1033A